Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer

KJ Cullen, Z Yang, L Schumaker, Z Guo - Journal of bioenergetics and …, 2007 - Springer
Cisplatin is among the most important chemotherapeutic agents ever developed. It is a
critical component of therapeutic regimens in a broad range of malignancies. However …

Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in the mitochondrial membrane of head and neck squamous cell …

Z Yang, LM Schumaker, MJ Egorin, EG Zuhowski… - Clinical cancer …, 2006 - AACR
Purpose: Cisplatin adducts to nuclear DNA (nDNA) are felt to be the molecular lesions that
trigger apoptosis, but the mechanism linking nDNA adduct formation and cell death is …

Mitochondrial involvement in cisplatin resistance

V Cocetta, E Ragazzi, M Montopoli - International journal of molecular …, 2019 - mdpi.com
Cisplatin is one of the worldwide anticancer drugs and, despite its toxicity and frequent
recurrence of resistance phenomena, it still remains the only therapeutic option for several …

Mitochondrial density determines the cellular sensitivity to cisplatin-induced cell death

W Qian, M Nishikawa, AM Haque… - … of Physiology-Cell …, 2005 - journals.physiology.org
We studied the relationship between the mitochondrial density in the cells and the cellular
sensitivity to the toxicity of cis-diaminedichloroplatinum II (cisplatin), a potent anticancer …

Mitochondria in chemotherapy-induced apoptosis: a prospective novel target of cancer therapy

D Decaudin, I Marzo, C Brenner… - … journal of oncology, 1998 - spandidos-publications.com
Resistance to apoptosis is a frequent characteristic of cancer cells and participates both in
the initial phase of carcinogenesis and in the development of chemotherapy resistance …

Immediate effects of anticancer drugs on mitochondrial oxygen consumption

AK Souid, KA Tacka, KA Galvan, HS Penefsky - Biochemical pharmacology, 2003 - Elsevier
The evolving role of mitochondria as a target for many anticancer drugs (eg platinum-based
compounds, alkylating agents and anthracyclines) prompted us to investigate their …

Mitaplatin increases sensitivity of tumor cells to cisplatin by inducing mitochondrial dysfunction

X Xue, S You, Q Zhang, Y Wu, G Zou… - Molecular …, 2012 - ACS Publications
Tumor resistance to chemotherapy is the major obstacle to employ cisplatin, one of the
broadly used chemotherapeutic drugs, for effective treatment of various tumors in the clinic …

Mitochondria as targets for established and novel anti-cancer agents

JM Grad, E Cepero, LH Boise - Drug Resistance Updates, 2001 - Elsevier
Chemoresistant cells have acquired the ability to evade the action of multiple classes of anti-
neoplastic compounds. One mechanism by which tumor cells survive in the presence of …

Drugs targeting mitochondrial functions to control tumor cell growth

N Dias, C Bailly - Biochemical pharmacology, 2005 - Elsevier
Mitochondria, the power houses of the cell, are at the cross-road of many cellular pathways.
They play a central role in energy metabolism, regulate calcium flux and are implicated in …

Characterization of mitochondria in cisplatin-resistant human ovarian carcinoma cells

M Hirama, S Isonishi, M Yasuda… - Oncology …, 2006 - spandidos-publications.com
One of the mechanisms of cisplatin cell cytotoxicity is the mitochondria-associated induction
of apoptosis. The morphological or functional change of mitochondria in cisplatin-resistant …